74. 下垂体性PRL分泌亢進症 Prolactin secreting pituitary adenoma Clinical trials / Disease details

臨床試験数 : 19 / 薬物数 : 28 - (DrugBank : 10) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 65

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04107480 (ClinicalTrials.gov)	June 21, 2019	27/8/2019	PRolaCT - Three Prolactinoma RCTs	PRolaCT - Three Multicenter Prolactinoma Randomized Clinical Trials	Prolactinoma;Prolactin-Producing Pituitary Tumor	Procedure: Endoscopic trans-sphenoidal adenoma resection;Drug: Dopamine Agonists	Leiden University Medical Center	NULL	Recruiting	18 Years	N/A	All	880	Phase 4	Netherlands
2	NCT03717454 (ClinicalTrials.gov)	December 1, 2018	14/10/2018	Dopamine D2 Receptors(D2R) Imaging in Prolactinomas	The Predictive Value of Positron Emission Tomography-Magnetic Resonance (PET-MR) Mediated DopamineD2 ...	Prolactinoma	Other: Surgery;Drug: Drug treatment	Zhebao Wu	Xinqiao Hospital of Chongqing;First Hospital of China Medical University;Beijing Tiantan Hospital;Fi ...	Not yet recruiting	18 Years	65 Years	All	50	N/A	NULL
3	NCT03038308 (ClinicalTrials.gov)	September 16, 2016	30/1/2017	Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole	Treatment of Hyperprolactinemia With the Non-ergoline DopamineAgonist Ropinirole: A Dose Escalation ...	Hyperprolactinemia;Prolactinoma	Drug: Ropinirole	Columbia University	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Active, not recruiting	18 Years	70 Years	All	23	Phase 1/Phase 2	United States
4	NCT03353025 (ClinicalTrials.gov)	January 1, 2016	20/2/2017	Study on Therapy of Non-invasive Prolactinoma	Prospective Randomized Clinical Study on Transsphenoidal or DopamineDrugs Therapy Treat Non-invasive ...	Prolactinoma	Procedure: transsphenoidal surgery treatment;Drug: dopamine agonist treatment	First Affiliated Hospital, Sun Yat-Sen University	NULL	Recruiting	18 Years	60 Years	All	394	N/A	China
5	NCT01620138 (ClinicalTrials.gov)	March 2010	18/9/2011	Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolacti ...	Somatostatin and DopamineReceptors Expression in Non-functioning Pituitary Adenomas and Resistant Pr ...	Non-functioning Pituitary Adenomas;Prolactinomas	Drug: Pasireotide;Drug: cabergoline	Universidade Federal do Rio de Janeiro	NULL	Completed	18 Years	N/A	All	21	Phase 2/Phase 3	Brazil

First Previous1Next Last